DolCas gets ‘good day letter’ from FDA for GRAS status of BCM- 95 curcumin

- Last updated on GMT

iStock
iStock

Related tags: Gras status, Food, Fda

The US Food and Drug Administration has issued a ‘No Questions’ response letter to DolCas BioTech, LLC, for its BCM-95 turmeric extract.

This follows a self-affirmation of the GRAS (Generally Recognized As Safe) status by an expert panel of scientists last year for its use in medical foods at a dose of 500 mg, twice a day.

The submission to the FDA includes use in yogurt, nutritional bars and smoothies at a maximum dose of 60 mg/ serving.

“Not all curcumin products are the same or have gone through the most rigorous safety reviews. The additional level of review that led to the FDA’s recent response reflects our commitment to ensuring the safety of our products go above and beyond what is commonplace in the industry,”​ said Dr. Shavon Jackson Michel, ND, Medical & Scientific Affairs Advisor.

“The FDA’s response adds further credence to our expert panel’s confirmation of GRAS status. This is a rare accomplishment and distinguishes BCM-95 as a product our customers can trust.”

Related topics: Suppliers, Botanicals

Related news

Related products

show more

Welcome to Blue California Specialty Ingredients

Welcome to Blue California Specialty Ingredients

Blue California | 11-Oct-2021 | Product Presentation

At Blue California, our mission is to produce innovative and sustainable, custom ingredient solutions that are not just unique, they are also inspirational...

Absocurcumin® - A Botanic Joint Health Ingredient

Absocurcumin® - A Botanic Joint Health Ingredient

BOTANIC HEALTHCARE (NZ) LTD | 02-Sep-2021 | Clinical Study

ABSOCURCUMIN® is a clinically proven standardized phytochemical composition derived from Turmeric, Curcuma longa. In a controlled study of 30 adults aged...

Related suppliers

Follow us

Products

View more

Webinars